Analysts revise Eli Lilly stock price targets

Eli Lilly (NYSE: LLY), one of the U.S.’s foremost pharmaceutical giants, faced a sharp 8% drop in its stock price after reporting disappointing third-quarter results, erasing nearly $70 billion from its market value.The pharmaceutical giant missed both earnings and revenue expectations, prompting several analysts to lower their price targets.LLY five-day stock price chart. Source: FinboldAt the time of writing, LLY stock is down over 8% in the 5-day chart to its press-time price of $818. Sales miss sparks i ...